( July 30, 2025, 8:17 AM EDT) -- SEATTLE — A Washington federal judge dismissed with prejudice an abuse of process counterclaim filed by medical centers and two physicians who prescribe patients compounded versions of tirzepatide, a Food and Drug Administration-approved drug for diabetes and weight loss, against Eli Lilly and Co., noting that “this is far from a close call.”...